AEM-28

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAEM-28
Drug Alias NameApolipoprotein E mimeticAEM-28
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionApolipoprotein B-100 modulatorsApolipoprotein E agonists
TargetsApolipoprotein EApolipoprotein B-100
Therapy Area/IndicationsHypercholesterolemiaHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesLipimetix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipimetix Development Llc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipoproteinemia Type II

Other Information

ATC CodeN/A
Related LinksN/A